Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
August 2013
August 2013
NCT00372593Uploaded 03-24-2021
Access via NCI by Request
PDS UID: nci-data-460
A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined With Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults
Files: NCT00372593-D3



Data DictionaryNCT00372593-D3-Data-Dictionary_2.pdf

DATANCT00372593-D3-Dataset_2.csv

OTHERREADME.pdf